Knowledge of Vascular Age Contributes to Improve the Collaboration Between Community Pharmacies and Primary Health Care Physicians in Reducing Blood Pressure in Hypertensive Patients.

NANot yet recruitingINTERVENTIONAL
Enrollment

1,246

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

November 1, 2026

Study Completion Date

December 1, 2026

Conditions
Hypertension and Cardiovascular Risk Factors
Interventions
DIAGNOSTIC_TEST

Standard BP intervention

Behavioral: lifestyle counseling will be given according to international guidelines to reduce blood pressure.

DIAGNOSTIC_TEST

EVA intervention

Behavioral: lifestyle counseling will be given according to international guidelines to reduce blood pressure. In contrast to BP arm, EVA arm will additionally reciuve counseling about vascular age.

Trial Locations (6)

4020

Austrian Chamber of Pharmacists, Upper Austria (APO), Linz

Upper Austrian Society for General and Family Medicine (OBGAM), Linz

28040

Instituto Pluridisciplinar, Universidad Complutense de Madrid, Madrid

37007

Unidad de investigación de Atención Primaria de Salamanca (APISAL). Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca

46520

Hospital de Sagunto, Sagunto (valencia)

3045-043

H&TRC - Health & Technology Research Center, Coimbra Health School, Polytechnic University of Coimbra, Coimbra

All Listed Sponsors
collaborator

Health Research Fund of ISCIII Spain

UNKNOWN

collaborator

AIT Austrian Institute of Technology GmbH

OTHER

collaborator

Institut et Haute Ecole de la Santé la Source

UNKNOWN

collaborator

Instituto Politécnico de Coimbra

UNKNOWN

collaborator

European Union

OTHER

lead

Enrique Rodilla

OTHER